REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

EULAV Asset Management's Holding History (CIK: 0001540826)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 500,000 Value ($000) $1,285 Avg Close Range
Q1 2024
Shares 500,000 Value ($000) $2,460 Avg Close Range
Q4 2023
Shares 630,000 Value ($000) $5,538 Avg Close Range
Q3 2023
Shares 600,000 Value ($000) $6,882 Avg Close Range
Q2 2023
Shares 160,000 Value ($000) $4,050 Avg Close Range
Q1 2023
Shares 105,000 Value ($000) $3,382 Avg Close Range
Q4 2022
Shares 170,000 Value ($000) $3,138 Avg Close Range